Dashboard
Manage Tickers

BCLIBRAINSTORM CELL THERAPEUTIC...

Nasdaq brainstorm-cell.com


$ 0.39 $ -0.02 (-6.5 %)    

Monday, 19-Aug-2024 13:03:19 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 480.15 $ -1.01 (-0.21 %)
DIA $ 408.54 $ -0.55 (-0.13 %)
SPY $ 558.65 $ -0.91 (-0.16 %)
TLT $ 98.68 $ 0.78 (0.8 %)
GLD $ 232.46 $ 0.85 (0.37 %)
$ 0.3568
$ 0.34 x 500
-- x --
-- - --
$ 0.13 - $ 1.81
349,890
na
25.41M
$ 1.29
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 08-14-2024 06-30-2024 10-Q
2 05-14-2024 03-31-2024 10-Q
3 04-01-2024 12-31-2023 10-K
4 11-14-2023 09-30-2023 10-Q
5 08-14-2023 06-30-2023 10-Q
6 05-15-2023 03-31-2023 10-Q
7 03-30-2023 12-31-2022 10-K
8 11-14-2022 09-30-2022 10-Q
9 08-15-2022 06-30-2022 10-Q
10 05-16-2022 03-31-2022 10-Q
11 03-28-2022 12-31-2021 10-K
12 11-15-2021 09-30-2021 10-Q
13 08-05-2021 06-30-2021 10-Q
14 04-26-2021 03-31-2021 10-Q
15 02-04-2021 12-31-2020 10-K
16 10-15-2020 09-30-2020 10-Q
17 08-05-2020 06-30-2020 10-Q
18 05-07-2020 03-31-2020 10-Q
19 02-18-2020 12-31-2019 10-K
20 11-14-2019 09-30-2019 10-Q
21 08-13-2019 06-30-2019 10-Q
22 05-10-2019 03-31-2019 10-Q
23 03-29-2019 12-31-2018 10-K
24 10-29-2018 09-30-2018 10-Q
25 07-23-2018 06-30-2018 10-Q
26 05-14-2018 03-31-2018 10-Q
27 03-08-2018 12-31-2017 10-K
28 10-17-2017 09-30-2017 10-Q
29 08-14-2017 06-30-2017 10-Q
30 05-15-2017 03-31-2017 10-Q
31 03-29-2017 12-31-2016 10-K
32 11-14-2016 09-30-2016 10-Q
33 08-11-2016 06-30-2016 10-Q
34 05-10-2016 03-31-2016 10-Q
35 03-09-2016 12-31-2015 10-K
36 11-16-2015 09-30-2015 10-Q
37 08-13-2015 06-30-2015 10-Q
38 05-14-2015 03-31-2015 10-Q
39 03-26-2015 12-31-2014 10-K
40 11-13-2014 09-30-2014 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

brainstorm-cell-q2-2024-gaap-eps-004-inline-cash-and-equivalents-of-35m
Brainstorm Cell Q2 2024 GAAP EPS $(0.04), ...
08/14/2024 11:07:06

Brainstorm Cell (NASDAQ:BCLI) reported quarterly losses of $(0.04) per share which met the analyst consensus estimate. This is ...

brainstorm-cell-therapeutics-updates-on-nurown-stem-cell-therapy-for-als
BrainStorm Cell Therapeutics Updates On Nu...
07/24/2024 12:33:11

CMC FDA Questions Resolved, PIIIb Rollout Begins, $4M Raised, Commercialization Team In Place; Signed CRO And Lined Up Commerci...

brainstorm-cell-therapeutics-says-on-july-18-received-mvls-deficiency-notice-from-nasdaq-listing-qualifications-department-staff
BrainStorm Cell Therapeutics Says On July ...
07/19/2024 20:11:03

maxim-group-upgrades-brainstorm-cell-to-buy-announces-2-price-target
Maxim Group Upgrades Brainstorm Cell to Bu...
07/11/2024 13:05:16

Maxim Group analyst Jason McCarthy upgrades Brainstorm Cell (NASDAQ:BCLI) from Hold to Buy and announces $2 price target.

brainstorm-cell-therapeutics-prices-40m-registered-direct-offering-of-11111111-shares-at-036share
BrainStorm Cell Therapeutics Prices $4.0M ...
06/27/2024 13:16:06

brainstorm-cell-therapeutics-reaches-alignment-with-fda-on-chemistry-manufacturing-and-control-aspects-of-phase-3b-nurown-clinical-trial-for-amyotrophic-lateral-sclerosis
BrainStorm Cell Therapeutics Reaches Align...
06/26/2024 12:05:26

BrainStorm Cell Therapeutics Inc. (NASDAQ:BCLI), a leading developer of adult stem cell therapeutics for neurodegenerative dise...

brainstorm-cell-therapeutics-taps-haro-hartounian-phd-as-coo-effective-june-18
BrainStorm Cell Therapeutics Taps Haro Har...
06/20/2024 10:05:30

BrainStorm Cell Therapeutics Inc. (NASDAQ:BCLI), a leading developer of adult stem cell therapeutics for neurodegenerative dise...

12-health-care-stocks-moving-in-fridays-after-market-session
12 Health Care Stocks Moving In Friday's A...
06/14/2024 20:31:12

12-health-care-stocks-moving-in-mondays-pre-market-session
12 Health Care Stocks Moving In Monday's P...
06/10/2024 12:06:22

12-health-care-stocks-moving-in-fridays-after-market-session
12 Health Care Stocks Moving In Friday's A...
05/24/2024 20:31:11

brainstorm-cell-therapeutics-to-present-new-biomarker-data-suggesting-als-patients-may-benefit-from-longer-term-treatment-with-nurown
BrainStorm Cell Therapeutics to Present Ne...
05/20/2024 10:01:26

BrainStorm Cell Therapeutics Inc. (NASDAQ:BCLI), a leading developer of adult stem cell therapeutics for neurodegenerative dise...

brainstorm-cell-q1-2024-adj-eps-005-beats-007-estimate
Brainstorm Cell Q1 2024 Adj EPS $(0.05) Be...
05/14/2024 20:53:10

Brainstorm Cell (NASDAQ:BCLI) reported quarterly losses of $(0.05) per share which beat the analyst consensus estimate of $(0.0...

brainstorm-cell-therapeutics-received-letter-from-nasdaq-indicating-co-had-not-regained-compliance-with-minimum-bid-price-requirement-by-april-29
Brainstorm Cell Therapeutics Received Lett...
05/03/2024 20:14:57

- SEC Filing

12-health-care-stocks-moving-in-tuesdays-after-market-session
12 Health Care Stocks Moving In Tuesday's ...
04/30/2024 20:31:25

reported-earlier-brainstorm-cell-therapeutics-announces-management-changes-as-it-plans-registrational-phase-3b-trial-of-nurown
Reported Earlier, BrainStorm Cell Therapeu...
04/17/2024 06:54:01

Bob Dagher, MD, Promoted to Chief Medical Officer Dr. Stacy Lindborg Stepping Down as Co-CEO and Transitioning to Board of D...

brainstorm-cell-therapeutics-regains-compliance-with-nasdaq-minimum-market-value-rule
BrainStorm Cell Therapeutics Regains Compl...
04/11/2024 10:02:49

BrainStorm Cell Therapeutics Inc. (NASDAQ:BCLI, ", , the Company", , )))), a leading developer of cellular therapies fo...

brainstorm-cell-therapeutics-announced-peer-reviewed-publication-of-phase-3-biomarker-data-in-muscle-and-nerve-suggesting-that-debamestrocel-or-nurown-may-impact-key-biomarkers-in-amyotrophic-lateral-sclerosis-that-are-predictive-of-disease-progression
Brainstorm Cell Therapeutics Announced Pee...
04/10/2024 10:02:28

12-health-care-stocks-moving-in-tuesdays-pre-market-session
12 Health Care Stocks Moving In Tuesday's ...
04/09/2024 12:09:53

why-biophytis-shares-are-trading-higher-by-around-55-here-are-20-stocks-moving-premarket
Why Biophytis Shares Are Trading Higher By...
04/09/2024 10:05:24

Shares of Biophytis S.A. (NASDAQ: BPTS) rose sharply in today’s pre-market trading after reporting FY23 results.

brainstorm-cell-therapeutics-received-written-agreement-from-fda-under-special-protocol-assessment-on-design-for-phase-3b-trial-of-nurown-in-amyotrophic-lateral-sclerosis-expected-to-start-in-2024
Brainstorm Cell Therapeutics Received Writ...
04/09/2024 10:02:50

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION